Latest News

The stock is plunging on fears that the AI data center boom's days could be numbered.

What happened? A number of stocks jumped in the afternoon session after semiconductor and hardware shares mounted a synchronized rebound from the sharp post-...

What happened? Shares of IT solutions provider ePlus (NASDAQ:PLUS) jumped 4.4% in the afternoon session after investors continued to bid up the stock as the ...

What happened? Shares of eyewear retailer Warby Parker (NYSE:WRBY) jumped 21.2% in the afternoon session after Investors continued to bid up the stock as the...

What happened? A number of stocks jumped in the afternoon session after Reuters reported that China has prolonged its export control relief on rare earth mat...

What happened? A number of stocks jumped in the afternoon session after Reuters reported that China has prolonged its export control relief on rare earth mat...

What happened? A number of stocks jumped in the afternoon session after semiconductor and hardware shares mounted a synchronized rebound from the sharp post-...

What happened? A number of stocks jumped in the afternoon session after semiconductor and hardware shares mounted a synchronized rebound from the sharp post-...

What happened? Shares of environmental services provider Onterris (NYSE:ONT) jumped 6.1% in the afternoon session after the company announced, in a company p...

Roughly $1.8 billion in fixed and adjustable-rate loans is expected to mature or be repriced through 2027.

Sequential growth returned, and a major OEM deal is nearing close.

Nvidia stock fell after the news.

These three brands keep winning customers even as their stocks slump, setting up better prospects for returns.

When you'll need your money soon, a sharp drop feels more personal. Here's how to protect your plan without giving up on stocks.

A tubeless patch pump launch and pharmacy channel momentum could reshape the company's margin profile within three years.

CVS Health (NYSE:CVS) executives said the company’s planned separation of its pharmacy business will create two companies capable of growing independently, while addressing investor questions about the costs and competitive implications of the transaction. Speaking at a Wolfe Research healthcare co

CNH Industrial (NYSE:CNH) raised its 2026 earnings and cash flow forecasts and announced a deal to place its construction equipment business in a joint venture with Kobelco Construction Machinery, as the company sharpens its focus on agriculture. The agreement values the construction business at $1

Orthofix Medical (NASDAQ:OFIX) lowered its 2026 outlook after third-quarter results fell short of management’s expectations, as softer U.S. spine procedure volumes and supplier delays constrained its ability to support demand. Third-quarter net sales were $207.9 million, up 2.3% year over year, wit

Roivant Sciences (NASDAQ:ROIV) reported $31 million in net revenue from the initial launch of LISRAYA and said an experimental rheumatoid arthritis treatment met its primary endpoint in a randomized withdrawal study. Chief Executive Officer Matt Gline said the LISRAYA revenue covered roughly five w

Uniti Group (NASDAQ:UNIT) raised its full-year revenue expectations after strong demand for its fiber infrastructure services, even as third-quarter earnings declined and competitive pressures weighed on its Kinetic broadband business. The company expects 2026 consolidated revenue of approximately

Sharplink Gaming (NASDAQ:SBET) reported a sharp increase in third-quarter profit as a rebound in Ether prices produced substantial gains on its digital asset holdings, while staking revenue also grew. Net income for the quarter ended September 30, 2026, rose to $751.4 million from $104.3 million a

Ocular Therapeutix (NASDAQ:OCUL) plans to submit a U.S. application in the fourth quarter of 2026 for AXPAXLI, its investigational treatment for wet age-related macular degeneration, executives said on the company’s third-quarter earnings call. The planned submission follows a September pre-applica

GCM Grosvenor (NASDAQ:GCMG) reported higher third-quarter fee-related revenue and earnings as assets and fundraising grew, and executives said they expect fundraising in the second half of 2026 to exceed the first half. Assets under management reached $98 billion, up 13% from a year earlier, while

monday.com (NASDAQ:MNDY) reported 19% revenue growth and a record non-GAAP operating margin in the third quarter of fiscal 2026, but executives said restructuring disruption, weakness among smaller customers and longer enterprise sales cycles were slowing growth. Revenue rose to $378 million, while

The mREIT's new buyback plan probably won't solve its near-term challenges.